{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:41:54Z","timestamp":1788385314579,"version":"build-2803163510"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"\n Importance<\/jats:title>\n Previous studies have described a potential association between epilepsy and frontotemporal dementia (FTD), but no systematic data are available.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether epilepsy is more prevalent in patients with FTD than in healthy controls (HCs) or patients with Alzheimer disease (AD).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n In this case-control study, we compared the prevalence of epilepsy and purchases of antiseizure medicines (ASMs) among patients with FTD, matched HCs, and patients with AD from 2 early-onset dementia diagnostics centers in the same geographic regions of Finland. AD or FTD diagnoses were made between January 1, 2010, and December 31, 2021. Data were analyzed from January 26, 2024, to January 16, 2025.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n The primary outcome was to describe the prevalence of epilepsy in patients with FTD, covering the time period from 10 years before to 5 years after the FTD diagnosis. We used\n International Statistical Classification of Diseases, Tenth Revision<\/jats:italic>\n codes to identify all patients with epilepsy and tracked purchases of ASMs.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The study cohort included 245 patients with FTD (121 female [49.4%], 124 male [50.6%]; mean [SD] age, 65.2 [8.7] years), 2416 matched HCs (1190 female [49.3%], 1226 male [50.7%]; mean [SD] age, 65.0 [8.5] years), and 1326 patients with AD (777 female [58.6%], 549 male [41.4%]; mean [SD] age, 71.7 [9.8] years). The prevalence of epilepsy was higher in the FTD group compared with the HC group (3.3% vs 0.8%, respectively;\n P<\/jats:italic>\n \u2009=\u2009.002) and AD group (3.3% vs 1.4%, respectively;\n P<\/jats:italic>\n \u2009=\u2009.01) 10 years before FTD diagnosis. At the year of the diagnosis, the prevalence was 6.5% in patients with FTD, 1.8% in HCs (FTD vs HC difference, 4.7 percentage points [ppt] [95% CI, 2.2-8.6 ppt];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and 5.0% in patients with AD (FTD vs AD difference, 1.6 ppt [95% CI, \u22121.2 to 5.5 ppt];\n P<\/jats:italic>\n \u2009=\u2009.32); at 5 years after the diagnosis, the prevalence was 11.2% in patients with FTD, 2.2% in HCs (FTD vs HC difference, 9.0 ppt [95% CI, 5.0-14.6 ppt];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and 6.9% in patients with AD (FTD vs AD difference, 4.2 ppt [95% CI, 0-10.0 ppt];\n P<\/jats:italic>\n \u2009=\u2009.05). ASM purchases were made significantly more often among patients with FTD (10.2%) compared with HCs (1.8%) and patients with AD (4.2%) (FTD vs HC difference, 8.4 ppt [95% CI, 5.2-12.9 ppt];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001; FTD vs AD difference, 6.1 ppt [95% CI, 2.6-10.6 ppt];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) at all time points and increased during the study period.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This case-control study found a higher prevalence of epilepsy and increased ASM use among patients with FTD compared with HCs and patients with AD , suggesting an association between epileptic abnormalities and the pathophysiology of FTD. Further studies are warranted to investigate a potential overlap in the pathophysiologic mechanisms of epilepsy and FTD.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaneurol.2025.1358","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:01:03Z","timestamp":1748862063000},"page":"715","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of Epilepsy in Frontotemporal Dementia and Timing of Dementia Diagnosis"],"prefix":"10.1001","volume":"82","author":[{"given":"Annemari","family":"Kilpel\u00e4inen","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine\u2013Neurology, University of Eastern Finland, Kuopio, Finland"},{"name":"Neuro Center\u2013Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Aaltonen","sequence":"additional","affiliation":[{"name":"Law School, University of Eastern Finland, Joensuu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Aho","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine\u2013Neurology, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Heikkinen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine\u2013Neurology, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ave","family":"Kivisild","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine\u2013Neurology, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfina","family":"Lehtonen","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Department of Neurology, University of Oulu, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lepp\u00e4nen","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Department of Neurology, University of Oulu, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iina","family":"Rinnankoski","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Department of Neurology, University of Oulu, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmi","family":"Soppela","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine\u2013Neurology, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tervonen","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Department of Neurology, University of Oulu, Oulu, Finland"},{"name":"Medical Research Center, Oulu University Hospital, Oulu, Finland"},{"name":"Neurocenter, Neurology, Oulu University Hospital, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Hartikainen","sequence":"additional","affiliation":[{"name":"Neuro Center\u2013Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annakaisa","family":"Haapasalo","sequence":"additional","affiliation":[{"name":"A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetta","family":"K\u00e4lvi\u00e4inen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine\u2013Neurology, University of Eastern Finland, Kuopio, Finland"},{"name":"Neuro Center\u2013Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Katisko","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine\u2013Neurology, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Kr\u00fcger","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Department of Neurology, University of Oulu, Oulu, Finland"},{"name":"Medical Research Center, Oulu University Hospital, Oulu, Finland"},{"name":"Neurocenter, Neurology, Oulu University Hospital, Oulu, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eino","family":"Solje","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine\u2013Neurology, University of Eastern Finland, Kuopio, Finland"},{"name":"Neuro Center\u2013Neurology, Kuopio University Hospital, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10004","key":"noi250028r1","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","article-title":"Frontotemporal dementia.","volume":"386","author":"Bang","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"noi250028r2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi250028r3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","article-title":"Frontotemporal dementia.","volume":"35","author":"Olney","year":"2017","journal-title":"Neurol Clin"},{"issue":"14","key":"noi250028r4","doi-asserted-by":"publisher","first-page":"11732","DOI":"10.3390\/ijms241411732","article-title":"Frontotemporal dementia, where do we stand? a narrative review.","volume":"24","author":"Antonioni","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"noi250028r5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2165\/11640070-000000000-00000","article-title":"Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.","volume":"26","author":"Seltman","year":"2012","journal-title":"CNS Drugs"},{"issue":"1","key":"noi250028r6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000351859","article-title":"Clinical characteristics of C9ORF72-linked frontotemporal lobar degeneration.","volume":"3","author":"Kaivorinne","year":"2013","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"noi250028r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108783","article-title":"Does epilepsy contribute to the clinical phenotype of C9orf72 mutation in fronto-temporal dementia?","volume":"133","author":"Muroni","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"3","key":"noi250028r8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2022.5128","article-title":"Incidence of syndromes associated with frontotemporal lobar degeneration in 9 European countries.","volume":"80","author":"Logroscino","year":"2023","journal-title":"JAMA Neurol"},{"issue":"3","key":"noi250028r9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JAD-210599","article-title":"A novel genetic marker for the C9orf72 repeat expansion in the Finnish population.","volume":"83","author":"Rostalski","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"noi250028r10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-170031","article-title":"Relative incidence of seizures and myoclonus in Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal dementia.","volume":"60","author":"Beagle","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"noi250028r11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1684\/epd.2021.1406","article-title":"Epilepsy in neurodegenerative diseases.","volume":"24","author":"Neri","year":"2022","journal-title":"Epileptic Disord"},{"key":"noi250028r12","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.637260","article-title":"Predictors of new-onset epilepsy in people with younger-onset neurocognitive disorders.","volume":"13","author":"Wang","year":"2021","journal-title":"Front Aging Neurosci"},{"issue":"pt 9","key":"noi250028r14","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"issue":"11","key":"noi250028r15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants.","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"noi250028r16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"2","key":"noi250028r18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1528-1157.1996.tb00005.x","article-title":"Prevalence of epilepsy in the elderly: the Rotterdam Study.","volume":"37","author":"de la Court","year":"1996","journal-title":"Epilepsia"},{"key":"noi250028r19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.seizure.2019.06.016","article-title":"The prevalence and clinical features of epileptic seizures in a memory clinic population.","volume":"71","author":"Baker","year":"2019","journal-title":"Seizure"},{"issue":"1-2","key":"noi250028r20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000443205","article-title":"Survival in frontotemporal dementia phenotypes: a meta-analysis.","volume":"41","author":"Kansal","year":"2016","journal-title":"Dement Geriatr Cogn Disord"},{"key":"noi250028r21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"noi250028r22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/JCP.0b013e31823f91b9","article-title":"Treatment of indiscriminate, inappropriate sexual behavior in frontotemporal dementia with carbamazepine.","volume":"32","author":"Poetter","year":"2012","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"noi250028r23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11940-014-0319-0","article-title":"Treatment of frontotemporal dementia.","volume":"16","author":"Tsai","year":"2014","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"noi250028r24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/153331750201700504","article-title":"Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration.","volume":"17","author":"Chow","year":"2002","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"2","key":"noi250028r25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-230494","article-title":"Psychopharmacological medication use in frontotemporal dementia at the time of diagnosis: comparison with Alzheimer\u2019s disease.","volume":"95","author":"Katisko","year":"2023","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"noi250028r26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub4","article-title":"Gabapentin for chronic neuropathic pain in adults.","volume":"6","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"noi250028r27","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/bcp.13844","article-title":"Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report.","volume":"85","author":"Supasitthumrong","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"noi250028r28","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awx327","article-title":"Neurotransmitter deficits from frontotemporal lobar degeneration.","volume":"141","author":"Murley","year":"2018","journal-title":"Brain"},{"key":"noi250028r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: an updated review.","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci"},{"issue":"3","key":"noi250028r30","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41380-021-01384-8","article-title":"Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration\u2014insights into disease mechanisms and current therapeutic approaches.","volume":"27","author":"Huber","year":"2022","journal-title":"Mol Psychiatry"},{"key":"noi250028r31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000051214","article-title":"Neurons and their dendrites in frontotemporal dementia.","volume":"10","author":"Ferrer","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"noi250028r32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance.","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi250028r33","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1212\/WNL.0000000000000583","article-title":"Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia.","volume":"83","author":"Dopper","year":"2014","journal-title":"Neurology"},{"key":"noi250028r34","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5003902","article-title":"The advance on frontotemporal dementia (FTD)'s neuropathology and molecular genetics.","volume":"2022","author":"Wang","year":"2022","journal-title":"Mediators Inflamm"},{"key":"noi250028r13","unstructured":"Sociodemographic factors and criminal behaviour preceding neurodegenerative disease\u2014retrospective register study (DEGERWD). ClinicalTrials.gov identifier: NCT06209515. Updated January 31, 2024. Accessed April 21, 2025. https:\/\/www.clinicaltrials.gov\/search?term=NCT06209515"},{"key":"noi250028r17","unstructured":"Statistics Finland. Accessed April 21, 2025. https:\/\/stat.fi\/en"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2834602\/jamaneurology_kilpelinen_2025_oi_250028_1751558082.62889.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:00:38Z","timestamp":1752505238000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2834602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.1358","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}